Nationwide Pharmaceutical LLC

Nationwide Pharmaceutical LLC, doing business as Medical Wholesale, is a veteran-owned, service-disabled veteran-owned small business based in San Antonio, Texas that supplies pharmaceuticals, medical supplies, and clinical decision-support subscriptions to federal healthcare agencies as a prime contractor on 688 awards since 2016. The company holds SBA certifications as both a Veteran-Owned Small Business and Service-Disabled Veteran-Owned Small Business, each valid through February 3, 2027, and competes predominantly under small-business set-asides across its prime footprint — the vast majority of its awards carry Total Small Business or SDVOSB sole-source designations.

Nationwide Pharmaceutical operates as an NABP-accredited drug distributor delivering concrete pharmaceutical and medical goods: prescription medications, over-the-counter drugs, wound dressings, medical-surgical supplies, and web-based clinical reference subscriptions (UpToDate, Medi-Span, drug information databases, dental databases). Representative work includes a $2.6 million firm fixed-price purchase order from VA Veterans Integrated Service Network 15 for a five-month supply of Tamsulosin under an SDVOSB sole-source set-aside (December 2024); a $1.9 million UpToDate subscription award from the Defense Health Agency for United States Army Medical Command (March 2023); a $743 thousand online drug information database award from VA VISN 2 under SDVOSB set-aside (October 2023); and a $8 million multiple-award Federal Supply Schedule contract for Drugs, Pharmaceuticals, and Hematology Related Products under Schedule 65 I B issued November 1, 2025, running through October 2030. The company also supplied UpToDate subscriptions to the Food and Drug Administration ($677,930, five-year SDVOSB award, May 2025), the CDC ($499,328 and $249,442 across two separate orders), the Centers for Disease Control and Prevention, and the Bureau of Prisons ($214,510 for UpToDate, August 2023).

Customer concentration is extreme and VA-dominated. The top five VA VISNs account for 76% of all awards by count, with VA VISN 15 anchoring the portfolio at 187 awards worth $15.7 million combined potential value. When ranked by dollar value, VISN 15 and VISN 12 together represent $26.9 million (roughly 34% of total potential value); the Defense Health Agency contributes $6 million across only two orders (a concentration signal: high-value but narrow customer base). The company has served 26 distinct federal agencies, but VA networks are the operating center. Recent activity has contracted sharply: 31 awards in 2022, 38 in 2023, 24 in 2024, 11 in 2025, and 3 year-to-date in 2026 — a declining trajectory over the past three years. Nine awards totaling $4.4 million in combined potential value reach ultimate completion within the next twenty-four months, exposing the vendor to recompete risk.

Nationwide Pharmaceutical holds a newly awarded multiple-award FSS contract (ceiling $8 million through October 2030) as its primary vehicle platform; the source also names five parent IDCs and BPAs generating task-order activity, including a VA Blanket Purchase Agreement (36 task orders, $859 thousand) and an IDC for Emergent First Fill Pharmacy Services valued at $1.56 million. The company operates as a 100% prime contractor — no subcontract revenue appears in the award portfolio. Service Contract Inventory data, which captures service contracts above the $150,000 threshold, reports minimal SCI activity: $578 thousand invoiced across FY2023 against 0.1 FTEs, indicating that the bulk of Nationwide Pharmaceutical's work is goods procurement (pharmaceuticals, supplies) rather than services, which falls outside SCI's scope. On the limited SCI-reportable service contracts, median government-paid rates ran around $5,524 per hour, with senior labor pricing reaching $6,271 per hour and entry-level rates near $3,071 per hour; the vendor performed 0% of hours through subcontractors on those contracts.

Nationwide Pharmaceutical's federal footprint is tightly integrated with VA consolidated mail outpatient pharmacy (CMOP) operations and clinical-reference-resource provisioning across the Veterans Health Administration. It does not appear on GWACs, civilian-agency IDIQs, or broad-based federal schedules beyond the FSS vehicle. The company's recompete exposure, declining award velocity, and customer concentration with VA networks — particularly VISN 15 — define near-term competitive terrain.

As a FDA registered private label distributor, Nationwide has the ability to provide a vast array of pharmaceutical and medical products in both original and customized packaging. Our team has significant past performance with pharmaceutical and other health services with the delivery of pharmacy benefits inclusive of Federal and multi-state pharmacy practice regulations. Nationwide Pharmaceutical's areas of expertise include, evaluation of plan performance, contracting, quantitative analysis/ evaluation, drug benefit design, formulary management, prior authorizations, medical necessities, dispensing limits and utilization management. Moreover, our established system and network for the delivery and distribution of prescription services provides efficient, comprehensive and high quality pharmaceutical care for the Veterans.